We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Beximco Pharma | LSE:BXP | London | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 40.50 | 39.00 | 42.00 | 41.40 | 40.50 | 40.50 | 30,494 | 08:00:25 |
Date | Subject | Author | Discuss |
---|---|---|---|
25/8/2020 13:17 | On what basis do you say that? What I read was that they have a license to manufacture and sell remdesivir only in Bangladesh. | jamzwright | |
21/8/2020 11:06 | Under the radar. They will be minting it with supplies of Covid treatments to existing International customers. | outsizeclothes.com | |
17/8/2020 12:13 | the isa position has been discussed several posts back | 3800 | |
17/8/2020 09:09 | I have mine in an HL ISA. | bobdouthwaite | |
16/8/2020 23:08 | You can add them to your SIPP, that’s where I have mine | neil1pat | |
16/8/2020 22:45 | Didn't realise that! Not the primary listing, so maybe that's the reason | leopoldalcox | |
16/8/2020 20:38 | Hi, i would've bought these but you can't have them in an ISA according to HL! Enjoy the run. | aberloon2 | |
04/8/2020 11:00 | It gets next to no coverage. I suspect as this is a secondary listing? Either way, very happy with it | leopoldalcox | |
04/8/2020 09:21 | Loving it! | elsa7878 | |
29/7/2020 13:29 | '...the company has raised production to 80,000 vials a month, with an eye toward doubling that by the end of August.' hxxps://asia.nikkei. | mfhmfh | |
27/7/2020 12:07 | good start to the week | mfhmfh | |
02/7/2020 15:12 | Let the BBC know - haveyoursay@bbc.co.u | outsizeclothes.com | |
01/7/2020 16:53 | It will be - IF the UK and other health boards realise that BXP is manufacturing it. There is bound to be scope too to actually make a [small] bit of profit on it too | outsizeclothes.com | |
01/7/2020 07:42 | As the US is buying all Gilead production, BXP remdesivir should now be in high demand. | bobdouthwaite |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions